Biotech Company Ginkgo To Merge With Harry Sloan-led SPAC in $17 billion deal
#biotechcompanyginkgo
#harry
#spac
3 years ago By Suzana — A merger deal will take Boston-headquartered biology building company Ginkgo Bioworks public at a $17 billion equity valuation. The deal, expected to occur